Genetic scissors snip away at sickle cell.
The first CRISPR gene editing therapy has been approved to treat sickle cell disease, heralding a new era of transformative genomic medicine. By precisely editing a single gene in a patient's stem cells, scientists can override the mutation that causes debilitating sickle cell...
Read More